Premium
Redo of percutaneous renal denervation in a patient with recurrent resistant hypertension after primary treatment success
Author(s) -
Lambert T.,
Nahler A.,
Leisch F.
Publication year - 2013
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.24753
Subject(s) - medicine , blood pressure , percutaneous , denervation , resistant hypertension , regimen , secondary hypertension , surgery , cardiology
A 79‐year‐old patient was treated with percutaneous renal denervation (RDN) due to resistant arterial hypertension in the summer of 2010. After primary treatment success with a decrease of blood pressure from 170/100 to 130/80 mm Hg 6 months postablation, the blood pressure rose again at 12 months despite maintenance of the pharmacologic regimen and the decision was made to perform a second RDN procedure. Three months following the second RDN procedure, blood pressure was lowered to 130/77 mm Hg. © 2012 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom